March 2024 updates to the website

The website has now been updated following March's LSCMMG

The following guidelines have been added/updated:

Lipid Management Guideline for Secondary Prevention CVD - updated

Recurrent UTI prophylactic antibiotic pathway - update to follow

Azithromycin information sheet - update to follow pending amendments and ratification

The following medicines have been added/updated following the latest Clinical Effectiveness Group (CEG) / Commissioning Resource Group (CRG) meeting:

Tirzepatide - Type 2 Diabetes (NICE TA924)

The following Items will be updated and added to the website following the next Clinical Effectiveness Group (CEG) / Commissioning Resource Group (CRG) Meeting:

Sucralfate - RAG review for different preparations

Daridorexant - treating long-term insomnia (NICE TA922)

Targeted-release budesonide - treating primary IgA nephropathy (NICE TA937)

Triptorelin - treatment of precocious puberty